Brian Kornblit

1.2k total citations
53 papers, 745 citations indexed

About

Brian Kornblit is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Brian Kornblit has authored 53 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 22 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Brian Kornblit's work include Hematopoietic Stem Cell Transplantation (32 papers), T-cell and B-cell Immunology (11 papers) and Acute Myeloid Leukemia Research (9 papers). Brian Kornblit is often cited by papers focused on Hematopoietic Stem Cell Transplantation (32 papers), T-cell and B-cell Immunology (11 papers) and Acute Myeloid Leukemia Research (9 papers). Brian Kornblit collaborates with scholars based in Denmark, United States and Germany. Brian Kornblit's co-authors include Brenda M. Sandmaier, Peter Garred, Henrik Sengeløv, Lars L. Vindeløv, Søren Lykke Petersen, Jens Zimmer, Lea Munthe‐Fog, Jan Bert Gramsbergen, Rainer Storb and Klaus Müller and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Brian Kornblit

51 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Kornblit Denmark	16	309	263	143	133	95	53	745
Alberto Bianchi Italy	17	270 0.9×	407 1.5×	173 1.2×	157 1.2×	67 0.7×	29	756
Yasufumi Kikuchi Japan	17	58 0.2×	272 1.0×	348 2.4×	76 0.6×	30 0.3×	51	807
Theresa Wampler Muskardin United States	13	101 0.3×	216 0.8×	220 1.5×	109 0.8×	61 0.6×	21	830
Grazyna Wieczorek Switzerland	21	48 0.2×	323 1.2×	279 2.0×	137 1.0×	92 1.0×	35	1.0k
Jean-Paul Beressi France	11	131 0.4×	144 0.5×	316 2.2×	71 0.5×	55 0.6×	20	1.2k
Orly Zelig Israel	15	299 1.0×	140 0.5×	172 1.2×	53 0.4×	40 0.4×	35	877
Fiorella Alfinito Italy	18	186 0.6×	338 1.3×	132 0.9×	65 0.5×	62 0.7×	41	794
Solomon A. Graf United States	13	62 0.2×	66 0.3×	313 2.2×	165 1.2×	74 0.8×	45	695
A. Merat Iran	14	166 0.5×	51 0.2×	167 1.2×	57 0.4×	40 0.4×	25	516
N. Klopp Germany	18	154 0.5×	282 1.1×	278 1.9×	47 0.4×	79 0.8×	32	943

Countries citing papers authored by Brian Kornblit

Since Specialization

Citations

This map shows the geographic impact of Brian Kornblit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Kornblit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Kornblit more than expected).

Fields of papers citing papers by Brian Kornblit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Kornblit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Kornblit. The network helps show where Brian Kornblit may publish in the future.

Co-authorship network of co-authors of Brian Kornblit

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Kornblit. A scholar is included among the top collaborators of Brian Kornblit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Kornblit. Brian Kornblit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kjeldsen, Lars, Henrik Sengeløv, Brian Kornblit, et al.. (2024). Outpatient Management of Patients Conditioned with Fludarabine and Treosulfan prior to Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 31(1). 28.e1–28.e10.

Sørum, Maria Ebbesen, Anne Ortved Gang, Dorte Tholstrup, et al.. (2024). Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, double-blind, placebo-controlled, investigator-initiated study. BMJ Open. 14(10). e089862–e089862. 2 indexed citations

Ostrowski, Sisse Rye, Niklas Rye Jørgensen, Niels Smedegaard Andersen, et al.. (2022). Pre-Transplantation Vitamin E Levels and Acute Graft-Versus-Host Disease after Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(3). S285–S285. 1 indexed citations

Ostrowski, Sisse Rye, Niklas Rye Jørgensen, Niels Smedegaard Andersen, et al.. (2022). Pre-transplantation vitamin E levels and acute graft-versus-host disease after non-myeloablative allogeneic hematopoietic cell transplantation. Transplant Immunology. 74. 101650–101650. 2 indexed citations

Rank, Cecilie Utke, Mette Klarskov Andersen, Lasse Hjort Jakobsen, et al.. (2021). Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based study. Leukemia & lymphoma. 63(2). 416–425. 2 indexed citations

Kornblit, Brian, Barry E. Storer, Niels Smedegaard Andersen, et al.. (2020). Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen–mismatched donors. Blood. 136(13). 1499–1506. 14 indexed citations

Sengeløv, Henrik, Jakob Werner Hansen, Niels Smedegaard Andersen, et al.. (2020). Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes. Biology of Blood and Marrow Transplantation. 26(6). 1091–1098. 9 indexed citations

Marquart, Hanne Vibeke, Lars P. Ryder, Niels Smedegaard Andersen, et al.. (2019). Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation. Frontiers in Immunology. 10. 1997–1997. 51 indexed citations

Kornblit, Brian, et al.. (2017). C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(3). 600–607. 10 indexed citations

10.

Kornblit, Brian, S J Lee, Stephen R. Spellman, et al.. (2016). YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome. Bone Marrow Transplantation. 51(12). 1556–1560. 3 indexed citations

11.

Kornblit, Brian & Klaus Müller. (2016). Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 52(4). 499–505. 19 indexed citations

12.

Kornblit, Brian, DG Maloney, Barry E. Storer, et al.. (2014). A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation. Haematologica. 99(10). 1624–1631. 28 indexed citations

13.

Kornblit, Brian, Christian Enevold, Tao Wang, et al.. (2014). Toll-Like Receptor Polymorphisms in Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(2). 259–265. 2 indexed citations

14.

Kornblit, Brian, Lea Munthe‐Fog, Jan Bonde, et al.. (2013). Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis—Experience from two prospective cohorts. Immunobiology. 218(10). 1227–1234. 32 indexed citations

15.

Kornblit, Brian, Wendy M. Leisenring, Erlinda B. Santos, Rainer Storb, & Brenda M. Sandmaier. (2013). Safety of treatment with DLA-identical or unrelated mesenchymal stromal cells in DLA-identical canine bone marrow transplantation. PubMed. 4(3). 95–101. 7 indexed citations

16.

Wilbur, D. Scott, Ming‐Kuan Chyan, Hirohisa Nakamae, et al.. (2012). Reagents for Astatination of Biomolecules. 6. An Intact Antibody Conjugated with a Maleimido-closo-Decaborate(2-) Reagent via Sulfhydryl Groups Had Considerably Higher Kidney Concentrations than the Same Antibody Conjugated with an Isothiocyanato-closo-Decaborate(2-) Reagent via Lysine Amines. Bioconjugate Chemistry. 23(3). 409–420. 59 indexed citations

17.

Kornblit, Brian, Mette Voldby Larsen, Tania Nicole Masmas, et al.. (2010). Degree of Predicted Minor Histocompatibility Antigen Mismatch Correlates with Poorer Clinical Outcomes in Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 16(10). 1370–1381. 12 indexed citations

18.

Masmas, Tania Nicole, Søren Lykke Petersen, Hans O. Madsen, et al.. (2008). Graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioning. American Journal of Hematology. 83(7). 563–569. 4 indexed citations

19.

Kornblit, Brian, et al.. (2005). β-Thalassemia Due to a Novel Nonsense Mutation at Codon 37 (TGG→TAG) Found in an Afghanistani Family. Hemoglobin. 29(3). 209–213. 10 indexed citations

20.

Gramsbergen, Jan Bert, et al.. (2002). Glutathione depletion in nigrostriatal slice cultures: GABA loss, dopamine resistance and protection by the tetrahydrobiopterin precursor sepiapterin. Brain Research. 935(1-2). 47–58. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact